New Nordic Healthbrands AB (publ)
Simbols: NNH.ST
STO
19.6
SEKTirgus cena šodien
-12.6719
P/E koeficients
0.0178
PEG koeficients
121.43M
MRK Cap
- 0.00%
DIV ienesīgums
New Nordic Healthbrands AB (publ) (NNH-ST) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 53.85 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 433.07 | 101.9 | 116.5 | 97 | ||||||||||||||||
balance-sheet.row.inventory | 408.14 | 105.1 | 110.2 | 116.5 | ||||||||||||||||
balance-sheet.row.other-current-assets | 54.39 | 9.1 | 0 | 2.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 949.46 | 230 | 237.3 | 228.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 16.37 | 4.4 | 3.2 | 2.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 11.6 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 11.6 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0.92 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.tax-assets | 10.23 | 10.2 | 7 | 4.2 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 33.43 | 3.1 | -7 | 0 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 72.55 | 19.1 | 14.3 | 10.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1022 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.account-payables | 324.31 | 86.4 | 66.5 | 66 | ||||||||||||||||
balance-sheet.row.short-term-debt | 135.72 | 26.6 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.tax-payables | 10.27 | 2 | 1.7 | 3.6 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 8.22 | 2.2 | 1.6 | 0 | ||||||||||||||||
Deferred Revenue Non Current | -0.27 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.94 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 66.61 | 25.3 | 22.6 | 7.6 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 9.16 | 2.8 | 1.6 | 3.4 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-liab | 583.3 | 143 | 139.1 | 118 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 24.78 | 6.2 | 6.2 | 6.2 | ||||||||||||||||
balance-sheet.row.retained-earnings | 300.07 | 96.8 | 106.4 | 114.1 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 413.92 | 99.8 | 106.4 | 0.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -300.07 | -96.8 | -106.4 | -0.5 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 438.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1022 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 438.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1022 | - | - | - | ||||||||||||||||
Total Investments | 9.57 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.total-debt | 143.94 | 28.8 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.net-debt | 90.09 | 15 | 37.6 | 12.5 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -8.61 | -6.2 | -4.7 | 28.5 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2.03 | 1.2 | 1.6 | 0.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 14.87 | 31.7 | -3.4 | -31.1 | ||||||||||||||||
cash-flows.row.account-receivables | -3.85 | 2.8 | -10.4 | -4.6 | ||||||||||||||||
cash-flows.row.inventory | -12.04 | 4.9 | 6.3 | -35.8 | ||||||||||||||||
cash-flows.row.account-payables | 30.77 | 24 | 0.8 | 9.3 | ||||||||||||||||
cash-flows.row.other-working-capital | 0.66 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -1.29 | 1.3 | -9 | -6.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 5.48 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -3.16 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.11 | -0.3 | 0 | -0.3 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -3.05 | -3.4 | -2.6 | -3 | ||||||||||||||||
cash-flows.row.debt-repayment | -28.42 | -21.2 | -24.3 | -22.9 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -7.7 | -9.3 | ||||||||||||||||
cash-flows.row.other-financing-activites | -7.01 | 0 | 48.7 | 44.2 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.96 | -21.2 | 16.6 | 12.1 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.14 | -0.3 | 0.3 | 0.3 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -1.68 | 3.1 | -1.2 | 1.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 53.85 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 55.53 | 10.7 | 11.9 | 10.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 5.48 | 28 | -15.5 | -7.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -3.16 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 2.31 | 25 | -18.4 | -10.6 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 537.81 | 533.8 | 487.5 | 514.8 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 370.92 | 536.3 | 169 | 164.8 | ||||||||||||||||
income-statement-row.row.gross-profit | 166.89 | -2.5 | 318.5 | 350 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0.67 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 139.45 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 360.46 | 0.7 | 323.2 | 321.5 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 546.99 | 537 | 492.3 | 486.3 | ||||||||||||||||
income-statement-row.row.interest-income | 0.72 | 0.1 | 0 | 0 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.61 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -2.07 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -2.07 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.61 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 2.03 | 1.2 | 2.8 | 0.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -7.15 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -9.19 | -3.2 | -4.7 | 28.5 | ||||||||||||||||
income-statement-row.row.income-before-tax | -11.26 | -5.9 | -5.2 | 28 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -1.09 | 0.3 | -2.3 | 6.7 | ||||||||||||||||
income-statement-row.row.net-income | -10.17 | -6.2 | -2.8 | 21.3 |
Biežāk uzdotie jautājumi
Kas ir New Nordic Healthbrands AB (publ) (NNH.ST) kopējie aktīvi?
New Nordic Healthbrands AB (publ) (NNH.ST) kopējie aktīvi ir 249060000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir 272769000.000.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.310.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 0.373.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir -0.019.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir -0.017.
Kāda ir New Nordic Healthbrands AB (publ) (NNH.ST) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir -6194000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 28824000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 672000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 9865000.000.